Saturday, 02 March 2024

 

 

LATEST NEWS Narendra Modi lays foundation stone for multiple development projects worth Rs 15,000 crores Amit Shah inaugurates the National Urban Cooperative Finance and Development Corporation Limited (NUCFDC) in New Delhi Cabinet Decisions HP Lt Governor Manoj Sinha addresses closing ceremony of Rotary Club’s week-long Mega Health Camp in Poonch and Rajouri Districts Lt Governor Manoj Sinha addresses National Commission for Women's event ‘Tu Bol' dedicated to Inspirational Women Lt Governor Manoj Sinha attends ‘Herath Milan Samaroh’ in Jammu Breast cancer awareness program by RBU Lt Governor addresses the inaugural ceremony of the industrial unit of Bloomtex Industries Pvt Ltd Former Member of Parliament, BJP Mahila Morcha delegation call on Lt Governor Lt Governor pays obeisance at Mahalakshmi Temple Pacca Danga Jammu Former Minister, DDC Member Poonch call on Lt Governor Tourism deptt working on renewed plan to make J&K a world famous tourist destination DC Ganderbal Shyambir reviews progress on SWM, Vishwakarma Scheme Div Com Ramesh Kumar chairs Shri Shiv Khori Shrine Board Meeting DC Doda Harvinder Singh reviews arrangements for month of Ramazan District Advisory Committee reviews implementation of PC&PNDT Act in Udhampur Director Animal Husbandry Purnima Mittal kick-starts 4th round of FMD Vaccination Lok Sabha Election, 2024: DC Shopian visits locations of proposed Strong Rooms & Dispatch Centres DC Budgam Akshay Labroo initiates beautification project at heritage Syed Ali Aali Balkhi Shrine Pakherpora Lok Sabha Elections-2024: DC Pulwama Dr. Basharat Qayoom inspect Dispatch & Receipt/ Strong Rooms DDC Ganderbal Shyambir inaugurates one-day Job Fair at Ganderbal

 

Covid positive donor hearts may impact post-transplant survival: Study

Omicron Variant, Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Liquid Medical Oxygen, Oximeter
Listen to this article

Web Admin

Web Admin

5 Dariya News

New York , 18 May 2023

Heart transplant recipients receiving organs from active Covid-19 positive donors may have an increased risk of death at six months and one year when compared to those receiving organs from people who recovered from the infectious disease, according to a study.

"These early trends should be concerning enough such that heart transplantation centres need to thoroughly evaluate and continue to weigh the risks/benefits of using hearts from active Covid-19 donors," said lead author Shivank Madan, cardiologist at the Center for Advanced Cardiac Therapy at Montefiore Medical Center/Albert Einstein College of Medicine in New York.

Researchers in this study sought to determine utilisation trends and outcomes of heart transplants using Covid donors.According to researchers, this data is especially important because Covid virus can cause endothelial dysfunction and myocardial injury in potential donors that may manifest only sub-clinically pre-transplant; currently there is no clear consensus regarding evaluation and use of Covid donors for heart transplants.

The study looked at more than 27,000 donors between May 2020 and June 2022; and at 239 heart transplants. Donors were considered Covid donors if they tested positive at any time during terminal hospitalisation.

Active Covid status was given to those who tested positive within two days of organ procurement and recently resolved Covid status was given to those who tested positive initially but became negative prior to procurement.

The results, published in the Journal of the American College of Cardiology, showed that those who received heart transplants from active Covid donors had increased risk of mortality at six months and one year (7 per cent vs 13.8 per cent at six months and 9.2 per cent vs. 23.2 per cent at one year for non-Covid-19 vs. active Covid, respectively).

Those who received transplants from recently resolved Covid donors had similar six-month and one-year mortality rates as those receiving transplants from non-Covid donors (7 per cent vs. 8.5 per cent at six months and 9.2 per cent vs. 13.6 per cent at one year for non-Covid vs. recently resolved Covid, respectively).

Limitations of the study include variation in the timing and frequency of Covid-19 testing during terminal hospitalisation and lack of information on Covid-19 disease activity, including Ct values to indicate viral load, date of disease onset and symptom burden, or vaccination status of donor or recipient.

 

Tags: Omicron Variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Liquid Medical Oxygen , Oximeter

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2024 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD